Discovery of a potent and selective adenylyl cyclase type 8 agonist by docking-based virtual screening
Discovery of a potent and selective adenylyl cyclase type 8 agonist by docking-based virtual screening
复制标题
通过基于对接的虚拟筛选发现有效且选择性的 8 型腺苷酸环化酶激动剂
DOI:
10.1016/j.bmcl.2019.126823
复制
发表时间:
2020
影响因子:
2.7
通讯作者:
Zhili Zuo
中科院分区:
文献类型:
--
作者:
Zhiying Weng;Guowei Xu;Dingyuan Chen;Yaqing Yang;Wen Shen;Shuqun Zhang;Liang-Liang Wang;Weimin Yang;Zhili Zuo
Adenylyl cyclases (ACs), which are responsible for catalyzing the conversion of adenosine triphosphate (ATP) into the second messenger cyclic adenosine monophosphate (cAMP), play a critical role in cell signal transduction. In this study, a combined approach involving docking-based virtual screening, with the combination of homology modeling followed by anin-vitro, and cell-based biological assay have been performed for discovering a class of novel potent and selective isoform adenylyl cyclase type 8 (AC8) agonist. The computer-aided virtual screening was used to identify fourteen virtual cluster compounds as potential hits which were further subjected to rigorous bioassays. A novel hit compound VHC-7 (ethyl 3-(2,4-dichlorobenzyl)-2-oxoindoline-3-carboxylate) was identified as a highly potent selective AC8 agonist with EC50value of 0.1052 ± 0.038 µM. Remarkably, the molecule herein reported can be explored further to discover greater number of hit compounds with better pharmacokinetic properties as well as to serve as a promising novel hit agonist of AC8 for the treatment of various central nervous system disorders and its associated diseases.